Downregulation of Rap1 promotes 5-fluorouracil-induced apoptosis in hepatocellular carcinoma cell line HepG2

Oncology Reports

Volumn 31, Issue 4, 2014, Pages 1691-1698

  Zha, Yong ^a   Gan, Ping ^a   Yao, Qian ^a   Ran, Feng Ming ^a   Tan, Jing ^a  

^a KUNMING MEDICAL UNIVERSITY   (China)

Author keywords

Apoptosis; Hepatocellular carcinoma; NF B; Rap1

Indexed keywords

FLUOROURACIL; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; RAP1 PROTEIN; TRANSCRIPTION FACTOR RELA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER GROWTH; CANCER INHIBITION; CELL GROWTH; CELL STRAIN HEPG2; CELL SURVIVAL; CONTROLLED STUDY; DOWN REGULATION; ENZYME REPRESSION; GENE SILENCING; GENETIC TRANSFECTION; IN VITRO STUDY; IN VIVO STUDY; LIVER CELL CARCINOMA; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TARGETING; QUANTITATIVE ANALYSIS; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TUMOR GROWTH; UPREGULATION;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; BLOTTING, WESTERN; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; DOWN-REGULATION; FLOW CYTOMETRY; FLUOROURACIL; HEP G2 CELLS; HETEROGRAFTS; HUMANS; IMMUNOHISTOCHEMISTRY; LIVER NEOPLASMS; MICE; MICE, INBRED BALB C; MICE, NUDE; MICROSCOPY, ELECTRON, TRANSMISSION; REAL-TIME POLYMERASE CHAIN REACTION; TELOMERE-BINDING PROTEINS; TRANSFECTION; TUMOR MARKERS, BIOLOGICAL;

EID: 84908139305     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2014.3033     Document Type: Article

References (21)

1. El-Serag HB and Rudolph KL: Hepatocellularcarcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 132: 2557-2576, 2007.
2. Tang ZY, Ye SL, Liu YK, et al: A decade's studies on metastasis of hepatocellular carcinoma. J Cancer Res Clin Oncol 130: 187-196, 2004.
3. Padhya KT, Marrero JA and Singal AG: Recent advances in the treatment of hepatocellular carcinoma. Curr Opin Gastroenterol 29: 285-292, 2013.
4. Sankari SL, Masthan KM, Babu NA, et al: Apoptosis in cancer - an update. Asian Pac J Cancer Prev 13: 4873-4878, 2012.
5. Wu J, Hu D and Zhang R: Depletion of Bmi-1 enhances 5-fluorouracil- induced apoptosis and autophagy inhepatocellular carcinoma cells. Oncol Lett 4: 723-726, 2012.
6. Wang H and Cho CH: Effect of NF-κB signaling onapoptosisin chronic inflammation-associated carcinogenesis. Curr Cancer Drug Targets 10: 593-599, 2010.
7. Gocho T, Uwagawa T, Furukawa K, et al: Combination chemotherapy of serine protease inhibitor nafamostat mesilate with oxaliplatin targeting NF-κB activation for pancreatic cancer. Cancer Lett 333: 89-95, 2013.
8. Monks NR, Biswas DK and Pardee AB: Blocking anti-apoptosis as a strategy for cancer chemotherapy: NF-κB asatarget. J Cell Biochem 92: 646-650, 2004.
9. Teo H, Ghosh S, Luesch H, et al: Telomere-independent Rap1 is an IKK adaptor and regulates NF-κB-dependent gene expression. Nat Cell Biol 12: 758-767, 2010.
10. Kaseb AO, Shindoh J, Patt YZ, et al: Modified cisplatin/ interferonα-2b/doxorubicin/5-fluorouracil (PIAF)chemotherapy in patients with no hepatitis orcirrhosis is associated with improved response rate, resectability, and survival of initially unresectable hepatocellularcarcinoma. Cancer119: 3334-3342, 2013.
11. Yamashita T: Current status of hepatocellular carcinoma treatment in Japan: hepaticarterialin fusion chemotherapy. Clin Drug Investig 32 (Suppl 2): 15-23, 2012.
12. Spallarossa P, Altieri P, Aloi C, et al: Doxorubicin induces senescenceorapoptosis in rat neo natal cardiomyocytes by regulating the expression levels of the telomere binding factors1 and 2. Am J Physiol Heart Circ Physiol 297: H2169-H2181, 2009.
13. Kato M, Nakayama M, Agata M, et al: Gene expression levels of humans helter in complex and shelter in-associated factors regulated by the topoisomerase II inhibitors doxorubicin and etoposide in human cultured cells. Tumour Biol 34: 723-733, 2013.
14. Biroccio A, Rizzo A, Elli R, et al: TRF2 inhibition triggers apoptosis and reduces tumourigenicity of human melanoma cells. Eur J Cancer 42: 1881-1888, 2006.
15. Oh BK, Jo Chae K, Park C, et al: Telomere shortening and telomerase reactivation in dysplastic nodules of human hepatocarcinogenesis. J Hepatol 39: 786-792, 2003.
16. Oh BK, Kim YJ, Park C, et al: Up-regulation of telomere-binding proteins, TRF1, TRF2, and TIN2 is related to telomere shortening during human multistep hepatocarcinogenesis. Am J Pathol 166: 73-80, 2005.
17. O'Connor MS, Safari A, Liu D, et al: The human Rap1 protein complex and modulation of telomere length. J Biol Chem 279: 28585-28591, 2004.
18. Hayden MS and Ghosh S: Shared principles in NF-κB signaling. Cell132: 344-362, 2008.
19. Körber MI, Klingenbrunner S, Bartsch R, et al: NF-κB addiction and resistance to 5-fluorouracil in a multi-stage colon carcinoma model. Int J Clin Pharmacol Ther 51: 35-37, 2013.
20. Zhang H, Ozaki I, Hamajima H, et al: Vitamin K2 augments 5-fluorouracil-induced growth inhibition of human hepatocellular carcinoma cells by inhibiting NF-κB activation. Oncol Rep 25: 159-166, 2011.
21. Cheng Q, Lee HH, Li Y, et al: Upregulation of Bcl-x and Bfl-1 asapotential mechanism of chemoresistance, which can be overcome by NF-κB inhibition. Oncogene19: 4936-4940, 2000.